Mirvie

Breana’s story captures the silent epidemic stirring within the maternal health crisis. She was diagnosed with both #preeclampsia and placenta abruption at 33 weeks, which put both her and her baby’s life at risk. Delivering her son pre-term, Breana’s son spent the first 2 weeks of his life in the NICU. Upwards of 60,000 women like Breana nearly die from #pregnancy complications annually. The status quo isn’t working. Rates of preeclampsia - a leading cause of maternal morbidity - have doubled in the last 15 years. Severe maternal morbidity has also doubled over the past two decades. Understanding the “why” behind who’s most at risk for complications like preeclampsia is critical to help solve the #maternalhealth crisis. It’s time to bring pregnancy health into the era of precision medicine. If we can biologically understand who’s at risk early in pregnancy and apply preventive care to those identified as high risk, we have a significantly improved opportunity to prevent preeclampsia or mitigate the severity of the disease. Clinical tools like Mirvie’s test can identify who is most at-risk for preeclampsia, allowing pregnant women and their care team to take every action possible to create the healthiest pregnancy. Read more in a new op-ed in Fast Company from Mirvie CEO Maneesh Jain about the near-miss crisis within pregnancy health and why breakthrough solutions like Mirvie’s test are needed to shatter the status quo and create a new, better standard of care. Explore more at: https://lnkd.in/gbn6Dvjm

What’s the future of pregnancy health look like? Caltech's Techer details Mirvie CEO and co-founder Maneesh Jain’s journey to push the field of pregnancy health into the 21st century by using #RNA to predict pregnancy complications months in advance. Read more on how Mirvie is modernizing #maternalhealth here: https://lnkd.in/gUqQs-89

There's a clear societal need and sound business case for investing in #maternalhealth. The status quo isn’t working as rates of pregnancy complications like preeclampsia and severe maternal morbidity continue to rise. Forward-thinking investors like Khosla Ventures are supporting companies like Mirvie to usher in a new era of #pregnancy health. Breakthrough tools like Mirvie’s test, which uses #RNA to predict pregnancy complications like #preeclampsia, can help reverse the maternal health crisis in concert with novel approaches to maternal care. Read more in Reuters on the compelling, untapped opportunity for #investors to prioritize funding maternal health technologies and breakthroughs: https://lnkd.in/d97WdjCX

The maternal health crisis raging through America is not going to end anytime soon without serious changes. Thank you Reuters and Amina N. for shining a light on this critical topic and the outstanding opportunity for investment, innovation and impact. It shocks so many people to hear that pregnancy is more dangerous today than it was 20 years ago. That is absolutely unacceptable, and as Khosla Ventures' Alex Morgan said to Reuters, "Saving the lives of mothers and babies is in everyone's interest." KV's strategy on investing in maternal health technologies vs. clinics will be an integral part of solving the maternal health crisis. Breakthroughs in biological innovation and tech like Mirvie's #RNA platform can help reverse the tide of this crisis, in concert with novel approaches to maternal care. Let's not let this article, and moment, pass by without action. There is a compelling, untapped opportunity for investors to prioritize funding maternal health technologies and breakthroughs; for entrepreneurs and founders to become part of the solution; and for researchers to push forward the frontiers of our limited knowledge of maternal health. 

We need more #womenshealth at SXSW! Take a minute to vote for Mirvie alongside Gameto, Frida and Ingeborg Investments to speak about the urgency of accelerating innovation targeting unmet needs in women's health. Voting ends Sunday, August 18 so cast yours today: https://lnkd.in/eTjNbQ6B

Help us get on stage alongside Gameto and Frida, highlighting the urgency surrounding innovation in women’s health at the #SXSW2025 Conference! The SXSW PanelPicker Community Voting is now open through Sunday, August 18th. Cast your vote and help make it happen:  https://lnkd.in/eTjNbQ6B It takes 2 minutes to vote and all you need to do is:  ✅ Visit the link above and create an account to vote 📩 Click on the link sent to your email with the subject line “SXSW Account Confirmation” ⬆️ Click on the up arrow on the upper right side of the page to submit your vote Thank you from the entire team at Mirvie for demanding that women’s health be a global priority!

The underlying biology of pregnancy has long been shrouded in mystery. Research is increasingly connecting what happens during pregnancy impacts a person’s health over the course of their lifetime. Samir Kaul, founding partner and managing director of Khosla Ventures, and Mirvie’s Maneesh Jain discuss how innovations in #pregnancyhealth are finally starting to offer clarity on what’s happening in utero and share how these breakthroughs can provide earlier opportunities to intervene and create better outcomes for moms and their babies. Read more here: https://lnkd.in/dicCAKNR

Exciting news - Mirvie has won the MedTech Breakthrough award for Best Overall Women’s Health Solution! 🎉 At Mirvie, we’re pioneering a new approach to understand the biology of pregnancy by leveraging #RNA to predict life-threatening complications months in advance. We’re thrilled to be recognized as a leader in women’s health and pregnancy health as we double down on innovation tackling the #maternalhealth crisis. 

ICYMI: Mirvie’s Maneesh Jain and General Catalyst’s Holly Maloney shed light on the full scope of the maternal health crisis and why we need all hands on deck to solve it. Read more in Fortune on this urgent call for action to create healthier futures for moms and babies: https://lnkd.in/gShafZPP

While Preeclampsia Awareness Month has come to a close, it’s critical to continue shining a light on the stories of preeclampsia survivors and highlight how prediction and prevention of #preeclampsia is possible. With technology soon available to provide objective risk data on preeclampsia, early awareness makes effective prevention possible. Visit PreeclampsiaPrevention.com to access our free toolkit for both pregnant patients and #physicians, including a discussion guide on preeclampsia when speaking with care teams and evidence-based strategies that can be incorporated into daily routines to prevent preeclampsia, including taking baby aspirin, monitoring blood pressure at-home, and more. And a special shout out to organizations like Preeclampsia Foundation and Endpreeclampsia.org who keep a spotlight on this life-threatening complication all year.